Document is current
Any future updates will be listed below
-
Authors
Jansen-Winkeln, B. https://orcid.org/0000-0002-3996-9391
Eberth, J. https://orcid.org/0000-0002-0289-3450
Moulla, Y. https://orcid.org/0000-0002-5936-0217
Mehdorn, M. https://orcid.org/0000-0002-0047-368X
Niebisch, S. https://orcid.org/0000-0001-7049-2854
Schierle, K. https://orcid.org/0000-0002-5188-5537
Bläker, H. https://orcid.org/0000-0002-2497-8172
Lordick, F. https://orcid.org/0000-0001-8591-9339
Gockel, I. https://orcid.org/0000-0001-7423-713X
Thieme, R. https://orcid.org/0000-0002-0537-3979
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03100708 at ClinicalTrials.govDocuments that mention this clinical trial
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study
https://doi.org/10.1007/s00432-022-04517-w
-
Funding
Funding for this research was provided by:
Medizinische Fakultät, Universität Leipzig (Junior Research Grant, Junior Research Grant)
Universität Leipzig
- License Information
-
More Information
Article History
Received: 6 October 2022
Accepted: 3 December 2022
First Online: 13 December 2022
Declarations
:
: The authors declare that there is no conflict of interest.
: The study was performed in accordance with the Declaration of Helsinki and was approved by the local ethics committee of the Faculty of Medicine of the University of Leipzig, Germany (No. 106-16-14032016).
: Written informed consent was obtained from all individual participants included in this study.
: Written informed consent was obtained from all individual participants included in this study.
